home All News open_in_new Full Article

Suiza autoriza a Pharmamar a comercializar terapia combinada contra cáncer de pulmón CPCP

La entidad nacional suiza de autorización y supervisión de medicamentos, Swissmedic, ha dado el visto bueno a la farmacéutica española Pharmamar para que comercialice una terapia combinada para tratar el cáncer de pulmón de célula pequeña (CPCP) en adultos, una modalidad agresiva y de rápido crecimiento con opciones médicas limitadas. En una nota remitida este […] The post Suiza autoriza a Pharmamar a comercializar terapia combinada contra cáncer de pulmón CPCP appeared first on Radio Intereconomía.


today 36 h. ago attach_file Science

attach_file Politics
attach_file Events
attach_file Politics
attach_file Events
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Events
attach_file Events
attach_file Events
attach_file Events
attach_file Economics
attach_file Events
attach_file Events
attach_file Events
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics


ID: 3985910201
Add Watch Country

arrow_drop_down